1
A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
Condition(s):Colorectal Cancer MetastaticLast Updated:September 1, 2021Not yet recruiting
Capecitabine: 2066 Clinical Trials, Page 1 of 207
Hide Studies Not Open or Pending
2
A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition
Condition(s):Colon Cancer; Breast CancerLast Updated:February 19, 2018Unknown status
3
A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors
Condition(s):Advanced Cancer; Refractory Cancer; Tumor GastricLast Updated:February 22, 2022Recruiting
4
Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative
Condition(s):Breast CancerLast Updated:March 24, 2022Active, not recruiting
5
Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
Condition(s):Metastatic Colorectal CancerLast Updated:April 27, 2017Unknown status
6
Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients
Condition(s):Pseudomyxoma PeritoneiLast Updated:April 11, 2022Recruiting
7
Association of Capecitabine Pharmacokinetics and Toxicity With Aging
Condition(s):Breast Cancer; Colorectal CancerLast Updated:March 14, 2018Unknown status
8
Lenvatinib and Capecitabine in Patients With Advanced Malignancies
Condition(s):Advanced Cancer; Malignant Neoplasm of Breast; Malignant Neoplasms of Bone and Articular Cartilage; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary TractLast Updated:June 26, 2017Withdrawn
9
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 3, 2022Recruiting
10
Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment
Condition(s):Metastatic Nasopharyngeal CarcinomaLast Updated:August 2, 2022Not yet recruiting